Paradoxical Roles of Foxp3+ T Cells during Infection: From Regulators to Regulators  by Belkaid, Yasmine
In a second model of inflammatory co-
litis induced by the rectal administration
of trinitrobenzene sulphonic acid (TNBS),
the authors again showed reduced co-
lonic pathology following treatment with
purified PSA. PSA treatment was associ-
ated with elevated production of the anti-
inflammatory cytokine interleukin-10 (IL-
10) by CD4 T cells in themesenteric lymph
nodes. This effect was confirmed in vitro
by stimulation of bone marrow-derived
dendritic cells and naive CD4 T cells with
purified PSA. The cocultured cells’ re-
lease of the inflammatory cytokine TNFa
in response to H. hepaticus was blocked
by addition of PSA, but this block in turn
was abrogated by an IL-10 blocking
antibody, suggesting that the protective
effect of PSA is due in large part to
induced IL-10 production. The role of
IL-10 in mediating the protective effects
of PSA was confirmed by adoptive trans-
fer of IL-10-deficient CD4+CD45Rbhigh T
cells into Rag/ mice followed by colo-
nization of the mice with H. hepaticus
with or without PSA. In the absence of
IL-10, PSA was no longer able to protect
the mice from developing colitis. It re-
mains to be seen exactly howPSA shapes
the CD4 T cell response; an interesting
question remaining to be evaluated is if
the protective, PSA-induced, IL-10-pro-
ducing CD4 T cells express the regulatory
T cell marker Foxp3.
The significance of this study is best
seen in association with this group’s
previous work (Mazmanian et al., 2005).
Conceptually, these studies support the
idea of coevolution of host and microbe
and the resultant symbiosis between the
two. New studies will be needed to evalu-
ate the multitude of commensal organ-
isms with which we live. It is likely that
other commensal organisms are also
capable of shaping the host’s immune
system, each in organism-specific ways.
Furthermore, it will be important to deter-
mine if B. fragilis plays a similar immuno-
modulatory role within the human intes-
tine as compared to the mouse intestine.
Are inflammatory bowel diseases, such
as Crohn’s disease, associated with a
reduction in B. fragilis colonization? The
possibility that the anti-inflammatory
properties of B. fragilis colonization or
administration of purified PSA could be
used as a therapeutic intervention for
human inflammatory bowel diseases is
an exciting area for further exploration.
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T cells expressing the transcription factor Foxp3 have been shown to limit immune responses against
microbes. In a recent issue of Science, Lund et al. support the idea that these cells can also coordinate
the early entrance of innate cells at the effector site and therefore positively contribute to protective immunity.Surviving an infection requires the genera-
tion of an appropriate immune response
in which effector responses are preservedwhile tissue damages are controlled. Such
control is tightly adapted to a given micro-
environment and requires a regulatory net-Cell Host & Mwork that constantly sense and readjust
local homeostasis. Various populations
of regulatory cells, including T cellsicrobe 3, June 2008 ª2008 Elsevier Inc. 341
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contribute to this regulation. These cells
play a dominant role in the maintenance
of peripheral homeostasis, and limitation
of their function results in fatal autoimmune
syndrome (Sakaguchi etal., 2001).Someof
the earliest studies of Foxp3+ regulatory T
(TReg) cells emphasized that suchcells con-
trol the extent of immune-mediated pathol-
ogy at mucosal sites (Maloy and Powrie,
2001). Activated TReg cells efficiently con-
trol self-and flora-reactive T cells and in-
nate responses in mousemodels of colitis,
thereby minimizing collateral tissue dam-
age (Powrie et al., 2003). A similar scenario
has been shown to occur during various
chronic infections, whereby TReg cells are
required to monitor the constant immune
response by the host and to prevent detri-
mental tissue damage. TReg-cell-mediated
control of immunopathologymaybepartic-
ularly important for protecting immune-
privileged environments or tissues with
highly specialized functions, such as the
liver or eyes. In a model in which mice
were infected in the eye with herpes sim-
plex virus (HSV), natural TReg cells were
shown to protect against the development
of virus-induced inflammatory lesions
(Suvas et al., 2004). Most available studies
both in human and experimental models
support the idea that limitation of TReg
function or number is usually associated
with enhanced immune responses and
subsequent better control of the infection
(Belkaid,2007). In their present study,using
a model of viral infection, Lund et al. (2008)
show evidence that TReg cells can also
positively contribute to the establishment
of protective immunity (Lund et al., 2008).
Following delivery via the natural route,
herpes simplex virus type 2 infection
(HSV-2) replicates initially in the vaginal
mucosa and rapidly disseminates into
the central nervous system, resulting in
fatal paralysis. Presence of plasmacytoid
dendritic cells (DC) and interferon-g
(IFN-g) production by natural killer (NK)
cells aswell as CD4+ T cells delays the on-
set of death by few days revealing the ex-
istence of a transient viral control (Lund
et al., 2008). During HSV-2 infection, as
previously described during several ex-
perimental viral infections, Foxp3+ TReg
cells expanded, accumulated at the pri-
mary site of infection, and displayed
enhanced suppressive function (Lund
et al., 2008). As expected, their elimination
led to enhanced immune responses in the342 Cell Host & Microbe 3, June 2008 ª2008regional lymph node (Lund et al., 2003).
However, paradoxically, this enhanced
immune response was associated with
exacerbated viral load in vaginal mucosa,
earlier dissemination in the central ner-
vous system, and accelerated fatal out-
come. Lund et al. (2008) postulated that
a change in the appropriate sequence of
immune cell entry could account for this
impaired early viral control. Indeed, TReg
depletion coincided with a dramatic re-
duction in the early recruitment of plasma-
cytoidDCandNKcells, a delayedarrival of
CD4+ T cells, and a strong reduction in IFN
level. Furthermore, TReg depletion was as-
sociated with exuberant chemokine pro-
duction in the regional lymph node by
both DC and stromal cells but CCL5 pro-
duction decreased in the vaginal mucosa;
CCL5 is a chemokine previously proposed
to be associated with plasmacytoid DC
migration (Shen and Iwasaki, 2006).
Thus, uncontrolled chemokine production
in the regional lymph node together with
their selective reduction in the vaginal mu-
cosa may account for the impaired or de-
layed migration to the infected site. Con-
trol of chemokines by TReg cells during
infection has been previously reported
but was associated with a distinct out-
come. In a model of herpes simplex virus
type 1 (HSV-1), the mechanism of TReg
control of stromal keratitis involved sup-
pressed antiviral immunity and impaired
expression of the molecule required for T
cell migration to lesion sites (Suvas et al.,
2004). While chemokine production dys-
regulation is a tempting hypothesis to
explain uncontrolled growth of the virus,
the mechanistic explanation for such
effect remains unclear. Other possibilities
may account for such outcomes such as
poor cell retention, status of activation of
host cells, differential cell survival, or
tissue and/or vascular damage in the ab-
sence of TReg cells. Furthermore, we can-
not exclude the possibility that following
TReg depletion, compensatory increase in
tissue-specific regulatorymediators could
account for local suppression of innate
responses. However, regardless of the
mechanistic explanation, the finding that
TReg cells can facilitate the arrival of innate
cells and therefore direct appropriate im-
mune responses is an intriguing concept.
What remains to be established is if this
paradoxical role for TReg cells is associ-
ated with specific microenvironments
and inflammatory settings, or representsElsevier Inc.a more general function. The vaginal mu-
cosa belongs to the mucosal immune
systemandhas similarities to the intestinal
mucosa, such as strong innate responses
aswell as the ability to induceboth protec-
tion against infections and tolerance
against antigens related to pregnancy or
commensal bacteria. In contrast to intesti-
nal mucosa, however, genital mucosa
contains fewer lymphocytes and is under
hormonal control, which influences both
the adaptive and innate immune re-
sponses. Infection in sites associated
with reproduction could be postulated to
be particularly dangerous, and TReg cells
may become, in some circumstances, an
active partner of protective responses.
Another possibility would be that such
functions of TReg cells may be associated
with high microbial replication and or in-
flammation. Indeed, in their study, Lund
et al. (2008) show that TReg depletion also
favors early viral replication in the liver dur-
ing lymphocytic choriomeningitis virus
(LCMV) infection. Thus, in highly dynamic
infection, TReg cells may be important to
restrain exuberant immune responses in
lymphoid organs and favor timely recruit-
ment of innate cells. On the other hand, re-
cently available tools allowing a more
complete depletion of TReg (Kim et al.,
2007; Lahl et al., 2007) may reveal that co-
ordination of early cell entry in target tis-
suesmay be amore general and unappre-
ciated role for TReg cells. Because in mice,
HSV-2 is a fatal infection, generalizing
such findings as well as the relevance for
host survival would have to be addressed
in a less aggressive setting or usinga natu-
ral host-pathogen interaction. Maintaining
peripheral homeostasis in the face of in-
fection not only requires efficient control
of immune responses but also the estab-
lishment of an immune response fit for
the invaded site. Given the wide spectrum
of host-pathogen interactions in terms of
microorganisms, virulence, duration, or
target tissue, the roles exerted by TReg
cells during infection are expected to be
diverse and adaptable.
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